RGEN
Repligen Corp
Price:  
155.99 
USD
Volume:  
495,600.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Fair Value

-104.30 %
Upside

As of 2024-12-13, the Fair Value of Repligen Corp (RGEN) is -6.71 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 155.99 USD, the upside of Repligen Corp is -104.30%.

Note: valuation result may not be accurate due to the company's negative EPS.

155.99 USD
Stock Price
-6.71 USD
Fair Price
FAIR VALUE CALCULATION

RGEN Fair Value

Peter Lynch's formula is:

RGEN Fair Value
= Earnings Growth Rate x TTM EPS
RGEN Fair Value
= 25.00 x -0.27
RGEN Fair Value
= -6.71

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income 21.40 59.90 128.30 186.00 41.58 87.44
YoY growth 28.92% 179.91% 114.19% 44.97% -77.65% 58.07%

RGEN Fair Value - Key Data

Market Cap (mil) 8,740.12
P/E
Forward P/E 136.23x
EPS -0.27
Avg earnings growth rate 58.07%
TTM earnings -15.04